Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Kjell Elgjo

186 publications found

Original articles

Elgjo K, Reichelt KL (2013)
Is there a final common path in malignancies?
Med Hypotheses, 81 (2), 357-60
DOI 10.1016/j.mehy.2013.04.017, PubMed 23722002

Mancinelli L, De Angelis PM, Annulli L, Padovini V, Elgjo K, Gianfranceschi GL (2009)
A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells
Mol Cancer, 8, 55
DOI 10.1186/1476-4598-8-55, PubMed 19646247

Elgjo K, Reichelt KL (2004)
Chalones: from aqueous extracts to oligopeptides
Cell Cycle, 3 (9), 1208-11
PubMed 15326370

Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
Bone Marrow Transplant, 34 (4), 345-50
DOI 10.1038/sj.bmt.1704568, PubMed 15170163

Reichelt WH, De Angelis PM, Knutsen HK, Husøy T, Elgjo K, Reichelt KL (2004)
The colon mitosis inhibitor pyroglutamyl-histidyl-glycine inhibits growth of non-tumorigenic colonic epithelial cells
Anticancer Res, 24 (2B), 587-91
PubMed 15160998

Reichelt WH, Iversen JG, Paulsen JE, Elgjo K, Reichelt KL (2004)
Pyroglutamyl-histidyl-glycine, the endogenous colon mitosis inhibitor, regulates cyclic AMP level in non-tumorigenic colonic epithelial cells
Anticancer Res, 24 (3a), 1465-8
PubMed 15274311

Liu Y, Reichelt WH, Luna L, Elgjo K, Reichelt KL (2003)
The effects of a growth-inhibiting tripeptide, acetylGlu-Ser-GlyNH2 (Ac-ESG), on gene expression and cell cycle progression of two lymphoma cell lines
Anticancer Res, 23 (4), 3159-65
PubMed 12926049

Reichelt WH, Yndestad A, Wright MS, Elgjo K, Haug T, Reichelt KL (2003)
The colon mitosis-inhibitor pyroglutamyl-histidyl-glycine alters expression of immediate-early cancer-related genes in HT-29 cells
Anticancer Res, 23 (2B), 1229-34
PubMed 12820376

Lindenskov PH, Paulsen JE, Reichelt KL, Elgjo K (2002)
Endogenous tetrapeptide from neuroblastoma and new-born pig brain inhibits neuroblastoma cell growth in vitro
Anticancer Res, 22 (5), 2847-51
PubMed 12530008

Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, Elgjo K, Jakobsen J, Lindal S, Warburg M, Fuglsang-Frederiksen A, Skullerud K (2001)
Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene
Ophthalmic Genet, 22 (4), 207-23
DOI 10.1076/opge.22.4.207.2220, PubMed 11803487

Eide N, Syrdalen P, Scheie D, Chen Y, Elgjo K, Kerty E, Brabrand K (2001)
Uveal melanomas with optic nerve extension: report of two cases diagnosed by transvitreal biopsy, one of them with a multicentric tumour
Acta Ophthalmol Scand, 79 (3), 322-5
DOI 10.1034/j.1600-0420.2001.790325.x, PubMed 11401650

Paulsen JE, Elgjo K (2001)
Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor
In Vivo, 15 (5), 397-401
PubMed 11695236

Liu Y, Elgjo K, Wright M, Reichelt KL (2000)
Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2)
Biochem Biophys Res Commun, 277 (3), 562-7
DOI 10.1006/bbrc.2000.3666, PubMed 11061994

Gembitsky DS, De Angelis PM, Reichelt KL, Elgjo K (2000)
An endogenous melanocyte-inhibiting tripeptide pyroGlu-Phe-GlyNH2 delays in vivo growth of monoclonal experimental melanoma
Cell Prolif, 33 (2), 91-9
DOI 10.1046/j.1365-2184.2000.00166.x, PubMed 10845253

Moum B, Ekbom A, Vatn MH, Elgjo K (1999)
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time
Am J Gastroenterol, 94 (6), 1564-9
DOI 10.1111/j.1572-0241.1999.01145.x, PubMed 10364026

Gembitsky DS, Reichelt KL, Elgjo K (1998)
Antiproliferative effect of the tripeptide pyroGlu-Phe-GlyNH2 on murine melanocytes: transitory delay of cell growth in vitro and the cell cycle specificity
Exp Cell Res, 243 (2), 367-74
DOI 10.1006/excr.1998.4164, PubMed 9743596

Taskén K, Schulz T, Elgjo K, Skullerud K, Relman D, Brubakk O (1998)
Diagnostic utility of the polymerase chain reaction in 2 cases of suspected Whipple disease
Arch Intern Med, 158 (7), 801-3
DOI 10.1001/archinte.158.7.801, PubMed 9554687

Gembitsky DS, Reichelt KL, Haakonsen P, Paulsen JE, Elgjo K (1998)
Identification of a melanocyte growth-inhibiting tripeptide and determination of its structure
J Pept Res, 51 (1), 80-4
DOI 10.1111/j.1399-3011.1998.tb00420.x, PubMed 9495595

Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325

Wang XL, Elgjo K, Haaskjold E (1996)
Regeneration of rat corneal epithelium is delayed by the inhibitory epidermal pentapeptide (EPP)
Acta Ophthalmol Scand, 74 (4), 361-3
DOI 10.1111/j.1600-0420.1996.tb00709.x, PubMed 8883551

Chen Y, Sandboe FD, Elgjo K, Refsum SB, Hansen E, Qvale G, Sandvig KU, Klyve P (1996)
The Norwegian Ophthalmological Society Autumn Meeting - Oslo, Norway, 1995
Acta Ophthalmol. Scand., 74 (1), 101

Elgjo K, Reichelt KL (1995)
Zinc and the mitosis-inhibitory epidermal pentapeptide (EPP) form a stimulatory chelated dimer
Arch Dermatol Res, 287 (8), 735-9
DOI 10.1007/BF01105798, PubMed 8554385

Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F (1994)
Risk factors in primary sclerosing cholangitis
J Hepatol, 21 (6), 1061-6
DOI 10.1016/s0168-8278(05)80618-x, PubMed 7699228

Reichelt K, Haakonsen P, Paulsen J, Kornstad R, Elgjo K (1994)
Difference in the distribution of low-molecular-weight peptides and amino-acids in normal and malignant-cells and tissues
Oncol Rep, 1 (6), 1107-12
DOI 10.3892/or.1.6.1107, PubMed 21607500

Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E (1994)
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis
Scand J Gastroenterol, 29 (8), 744-52
DOI 10.3109/00365529409092504, PubMed 7973436

Elgjo K, Reichelt KL (1994)
Beta-receptor blockade by propranolol modifies the effect of the inhibitory, endogenous epidermal pentapeptide on epidermal cell flux at the G2-M transition but not at the G1-S transition
Epithelial Cell Biol, 3 (1), 32-7
PubMed 8193666

Nordøy I, Schrumpf E, Elgjo K, Flesland O, Andersen Glende J, Orjasaeter H, Siebke JC (1994)
Liver disease in anti-hepatitis C virus-positive Norwegian blood donors
Scand J Gastroenterol, 29 (1), 77-81
DOI 10.3109/00365529409090441, PubMed 8128181

Iversen OH, Elgjo K, Paulsen JE, Reichelt KL (1993)
Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide
Carcinogenesis, 14 (12), 2537-42
DOI 10.1093/carcin/14.12.2537, PubMed 8269624

Saebø A, Elgjo K, Lassen J (1993)
Could development of malignant mesothelioma be induced by Yersinia enterocolitica infection?
Med Hypotheses, 40 (5), 275-7
DOI 10.1016/0306-9877(93)90005-b, PubMed 8350778

ELGJO K (1993)
PENTAPEPTIDE GROWTH-INHIBITORS, CARCINOGENESIS, AND CANCER
NEW FRONTIERS IN CANCER CAUSATION, 125-137

Paulsen JE, Hall KS, Rugstad HE, Reichelt KL, Elgjo K (1992)
The synthetic hepatic peptides pyroglutamylglutamylglycylserylasparagine and pyroglutamylglutamylglycylserylaspartic acid inhibit growth of MH1C1 rat hepatoma cells transplanted into Buffalo rats or athymic mice
Cancer Res, 52 (5), 1218-21
PubMed 1310641

Ushmorov AA, Danilov AO, Zubova SG, Elgjo K, Okulov VB (1992)
Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide
Virchows Arch B Cell Pathol Incl Mol Pathol, 62 (6), 353-6
DOI 10.1007/BF02899703, PubMed 1360722

Hagve TA, Myrseth LE, Schrumpf E, Blomhoff JP, Christophersen B, Elgjo K, Gjone E, Prydz H (1991)
Liver steatosis in hypobetalipoproteinemia. A case report
J Hepatol, 13 (1), 104-11
DOI 10.1016/0168-8278(91)90871-8, PubMed 1918873

Paulsen JE, Sundby-Hall K, Endresen L, Rugstad HE, Reichelt KL, Elgjo K (1991)
The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro
Carcinogenesis, 12 (2), 207-10
DOI 10.1093/carcin/12.2.207, PubMed 1995186

Fausa O, Schrumpf E, Elgjo K (1991)
Relationship of inflammatory bowel disease and primary sclerosing cholangitis
Semin Liver Dis, 11 (1), 31-9
DOI 10.1055/s-2008-1040420, PubMed 2047887

Elgjo K, Reichelt KL, Clausen OP, de Angelis P (1991)
Inhibitory epidermal pentapeptide modulates proliferation and differentiation of transformed mouse epidermal cells in vitro
Virchows Arch B Cell Pathol Incl Mol Pathol, 60 (3), 161-4
DOI 10.1007/BF02899542, PubMed 1679266

Gabrielsen TO, Elgjo K, Sommerschild H (1991)
Eccrine angiomatous hamartoma of the finger leading to amputation
Clin Exp Dermatol, 16 (1), 44-5
DOI 10.1111/j.1365-2230.1991.tb00294.x, PubMed 2025934

Paus R, Stenn KS, Elgjo K (1991)
The epidermal pentapeptide pyroGlu-Glu-Asp-Ser-GlyOH inhibits murine hair growth in vivo and in vitro
Dermatologica, 183 (3), 173-8
DOI 10.1159/000247664, PubMed 1743383

Schrumpf E, Elgjo K, Fausa O, Haukenes G, Kvale D, Rollag H (1990)
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Scand J Gastroenterol, 25 (11), 1169-74
DOI 10.3109/00365529008998550, PubMed 2177219

Jensen PK, Elgjo K, Laerum OD, Bolund L (1990)
Synthetic epidermal pentapeptide and related growth regulatory peptides inhibit proliferation and enhance differentiation in primary and regenerating cultures of human epidermal keratinocytes
J Cell Sci, 97 ( Pt 1), 51-8
DOI 10.1242/jcs.97.1.51, PubMed 2258392

Jacobsen MB, Fausa O, Elgjo K, Schrumpf E (1990)
Hepatic lesions in adult coeliac disease
Scand J Gastroenterol, 25 (7), 656-62
DOI 10.3109/00365529008997589, PubMed 2396080

Bjøro K, Schrumpf E, Elgjo K, Nordgård K (1990)
[Chronic non-A non-B hepatitis treated with interferon]
Tidsskr Nor Laegeforen, 110 (11), 1346-8
PubMed 2111053

Schrumpf E, Fausa O, Aadland E, Elgjo K, Kolmannskog F (1990)
[Primary sclerosing cholangitis and inflammatory bowel disease]
Tidsskr Nor Laegeforen, 110 (10), 1212-6
PubMed 1970674

Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E (1990)
Factors of prognostic importance in primary biliary cirrhosis
Scand J Gastroenterol, 25 (2), 119-26
DOI 10.3109/00365529009107932, PubMed 2305209

Elgjo K, Reichelt KL (1990)
Mouse epidermal cell renewal after topical treatment with different concentrations of the epidermal peptide pyroGlu-Glu-Asp-Ser-GlyOH
Virchows Arch B Cell Pathol Incl Mol Pathol, 59 (2), 89-93
DOI 10.1007/BF02899392, PubMed 1977237

Reichelt KL, Paulsen JE, Elgjo K (1990)
Isolation of a growth and mitosis inhibitory peptide from mouse liver
Virchows Arch B Cell Pathol Incl Mol Pathol, 59 (3), 137-42
DOI 10.1007/BF02899398, PubMed 1980760

Olsen WM, Elgjo K (1990)
UVB-induced epidermal hyperproliferation is modified by a single, topical treatment with a mitosis inhibitory epidermal pentapeptide
J Invest Dermatol, 94 (1), 101-6
DOI 10.1111/1523-1747.ep12873961, PubMed 2295825

Watt FM, Reichelt KL, Elgjo K (1989)
Pentapeptide inhibitor of epidermal mitosis: production and responsiveness in cultures of normal, transformed and neoplastic human keratinocytes
Carcinogenesis, 10 (12), 2249-53
DOI 10.1093/carcin/10.12.2249, PubMed 2591014

Iversen OH, Elgjo K, Reichelt KL (1989)
Enhancement of methylnitrosourea-induced skin tumorigenesis and carcinogenesis in hairless mice by pretreatment with a mitosis-inhibiting epidermal pentapeptide
Carcinogenesis, 10 (2), 241-4
DOI 10.1093/carcin/10.2.241, PubMed 2912574

Valnes K, Brandtzaeg P, Stave R, Elgjo K (1988)
Local immune defence in relation to gastritis in Billroth-II-resected stomachs
Scand J Gastroenterol, 23 (10), 1217-24
DOI 10.3109/00365528809090194, PubMed 3074456

Aase S, Elgjo K, Fausa O, Bjørneklett A, Nedenskov-Sørensen P, Bukholm G (1988)
Bacteria of the gastric antrum and their relation to chronic gastritis
APMIS, 96 (3), 273-9
DOI 10.1111/j.1699-0463.1988.tb05301.x, PubMed 3348915

Elgjo K, Reichelt KL (1988)
Structure and function of growth inhibitory epidermal pentapeptide
Ann N Y Acad Sci, 548, 197-203
DOI 10.1111/j.1749-6632.1988.tb18807.x, PubMed 3247998

ELGJO K, REICHELT KL (1988)
STRUCTURE AND FUNCTION OF GROWTH INHIBITORY EPIDERMAL PENTAPEPTIDE
Ann.NY Acad.Sci., 548, 197-203
DOI 10.1111/j.1749-6632.1988.tb18807.x

Valnes K, Brandtzaeg P, Elgjo K, Stave R, Baklien K, Fausa O (1987)
Local immunoglobulin production is different in gastritis associated with dermatitis herpetiformis and simple gastritis
Gut, 28 (12), 1589-94
DOI 10.1136/gut.28.12.1589, PubMed 3428685

Rognum TO, Brandtzaeg P, Elgjo K, Fausa O (1987)
Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis
Br J Cancer, 56 (4), 419-24
DOI 10.1038/bjc.1987.217, PubMed 2446645

Reichelt KL, Elgjo K, Edminson PD (1987)
Isolation and structure of an epidermal mitosis inhibiting pentapeptide
Biochem Biophys Res Commun, 146 (3), 1493-501
DOI 10.1016/0006-291x(87)90818-7, PubMed 3619940

Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987)
Primary sclerosing cholangitis: a long-term follow-up study
Scand J Gastroenterol, 22 (6), 655-64
DOI 10.3109/00365528709011139, PubMed 3659828

Kvale D, Schrumpf E, Brandtzaeg P, Solberg HE, Fausa O, Elgjo K (1987)
Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease
J Hepatol, 4 (2), 229-35
DOI 10.1016/s0168-8278(87)80085-5, PubMed 3584932

Bøhmer T, Elgjo K, Hovig T, Jacobsen CD, Bakken A, Skagseth E, Skrede S (1987)
Postoperative jaundice in patients undergoing cardiac surgery. An incomplete cholestatic syndrome of multifactorial etiology
J Oslo City Hosp, 37 (11-12), 135-42
PubMed 3437345

Elgjo K, Reichelt KL, Hennings H, Michael D, Yuspa SH (1986)
Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells
J Invest Dermatol, 87 (5), 555-8
DOI 10.1111/1523-1747.ep12455733, PubMed 3772149

Elgjo K, Hennings H, Clausen OP (1986)
Altered growth kinetics precede calcium-induced differentiation in mouse epidermal cells
In Vitro Cell Dev Biol, 22 (6), 332-6
DOI 10.1007/BF02623407, PubMed 3759789

Valnes K, Brandtzaeg P, Elgjo K, Stave R (1986)
Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy
Gut, 27 (5), 505-14
DOI 10.1136/gut.27.5.505, PubMed 3516804

Vatn MH, Tjora S, Elgjo K, Norheim A, Bergan A (1985)
Lactate dehydrogenase isoenzymes in mucosal biopsy specimens from patients with ulcerative colitis
Scand J Gastroenterol, 20 (8), 929-32
DOI 10.3109/00365528509088849, PubMed 4081630

Lind E, Fausa O, Elgjo K, Gjone E (1985)
Crohn's disease. Clinical manifestations
Scand J Gastroenterol, 20 (6), 665-70
DOI 10.3109/00365528509089192, PubMed 4035286

Lind E, Fausa O, Elgjo K, Gjone E (1985)
Crohn's disease. Diagnostic procedures and problems
Scand J Gastroenterol, 20 (6), 660-4
DOI 10.3109/00365528509089191, PubMed 4035285

Clausen OP, Kirkhus B, Elgjo K, Pedersen S, Bolund L (1985)
DNA synthesis rate changes during the S phase in mouse epidermis
Cell Tissue Kinet, 18 (4), 445-55
DOI 10.1111/j.1365-2184.1985.tb00674.x, PubMed 4005938

Opedal I, Ritland S, Elgjo K (1985)
Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade
Scand J Gastroenterol Suppl, 107, 52-7
DOI 10.3109/00365528509099752, PubMed 3856935

Vatn MH, Jellum E, Elgjo K, Bergan A (1985)
Enzyme activity and protein patterns as premalignant markers in mucosal biopsy specimens from the large intestine
Scand J Gastroenterol Suppl, 107, 1-7
DOI 10.3109/00365528509099746, PubMed 3856932

Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo K (1985)
Follow-up and prospective studies of the classification of liver disease
Scand J Gastroenterol Suppl, 107, 40-51
DOI 10.3109/00365528509099751, PubMed 3856934

Vatn MH, Elgjo K, Norheim A, Bergan A (1984)
Measurement of enzyme activity in colonic biopsies: a test for premalignancy in ulcerative colitis?
Scand J Gastroenterol, 19 (7), 889-92
DOI 10.1080/00365521.1984.12005826, PubMed 6531657

Vatn MH, Elgjo K, Bergan A (1984)
Distribution of dysplasia in ulcerative colitis
Scand J Gastroenterol, 19 (7), 893-5
DOI 10.1080/00365521.1984.12005827, PubMed 6531658

Elgjo K, Reichelt KL (1984)
Purification and characterization of a mitosis inhibiting epidermal peptide
Cell Biol Int Rep, 8 (5), 379-82
DOI 10.1016/0309-1651(84)90140-1, PubMed 6234998

Valnes K, Brandtzaeg P, Elgjo K, Stave R (1984)
Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin
Gastroenterology, 86 (3), 402-12
PubMed 6198236

Schrumpf E, Ritland S, Gjone E, Elgjo K, Smevik B (1984)
[Primary liver cancer. Diagnosis, therapy and prognosis]
Tidsskr Nor Laegeforen, 104 (3), 147-9
PubMed 6701849

Digernes V, Elgjo K (1984)
Dimethyl nitrosamine-induced proliferative and neoplastic lesions in the mouse liver characterized by histopathology and flow cytometric DNA measurements
Acta Pathol Microbiol Immunol Scand A, 92 (1), 45-53
DOI 10.1111/j.1699-0463.1984.tb04376.x, PubMed 6322513

Evensen SA, Ritland S, Elgjo K, Solberg HE, Skrede S (1984)
Incorporation of precursors into sterols and proteins in liver biopsies from patients with liver disorders
Scand J Gastroenterol, 19 (1), 6-13
DOI 10.1080/00365521.1984.12005676, PubMed 6143395

Clausen OP, Elgjo K, Kirkhus B, Pedersen S, Bolund L (1983)
DNA synthesis in mouse epidermis: S phase cells that remain unlabeled after pulse labeling with DNA precursors progress slowly through S
J Invest Dermatol, 81 (6), 545-9
DOI 10.1111/1523-1747.ep12523189, PubMed 6644097

Elgjo K, Clausen OP (1983)
Mouse epidermal cell proliferation after a single application of dimethyl sulphoxide (DMSO)
Cell Tissue Kinet, 16 (4), 343-9
PubMed 6861193

Elgjo K, Clausen OP (1983)
Proliferation-dependent effect of skin extracts (chalone) on mouse epidermal cell flux at the G1-S, S-G2 and G2-M transitions
Virchows Arch B Cell Pathol Incl Mol Pathol, 42 (2), 143-51
DOI 10.1007/BF02890377, PubMed 6133388

Husby G, Blomhoff JP, Elgjo K, Williams RC (1982)
Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease
Scand J Gastroenterol, 17 (7), 855-60
DOI 10.3109/00365528209181105, PubMed 6296994

Rognum T, Elgjo K, Brandtzaeg P, Orjasaeter H, Bergan A (1982)
Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma
J Clin Pathol, 35 (9), 922-33
DOI 10.1136/jcp.35.9.922, PubMed 6749906

Rognum TO, Thorud E, Elgjo K, Brandtzaeg P, Orjasaeter H, Nygaard K (1982)
Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma
Br J Cancer, 45 (6), 921-34
DOI 10.1038/bjc.1982.145, PubMed 7046779

Rognum TO, Elgjo K, Fausa O, Brandtzaeg P (1982)
Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia
Gut, 23 (2), 123-33
DOI 10.1136/gut.23.2.123, PubMed 7040173

Clausen OP, Thorud E, Elgjo K (1982)
Epidermal proliferation characteristics are similar in the pilary canal of mouse hair follicles and in interfollicular epidermis
Virchows Arch B Cell Pathol Incl Mol Pathol, 39 (3), 259-66
DOI 10.1007/BF02892852, PubMed 6126031

Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjone E (1982)
Sclerosing cholangitis in ulcerative colitis. A follow-up study
Scand J Gastroenterol, 17 (1), 33-9
DOI 10.3109/00365528209181041, PubMed 7134835

Smevik B, Kolmannskog F, Elgjo K, Ritland S (1981)
[Computer tomography of fatty liver]
Tidsskr Nor Laegeforen, 101 (25), 1387-9
PubMed 7339926

Hennings H, Devor D, Wenk ML, Slaga TJ, Former B, Colburn NH, Bowden GT, Elgjo K, Yuspa SH (1981)
Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice
Cancer Res, 41 (3), 773-9
PubMed 6780187

Isaksson-Forsén G, Elgjo K, Burton D, Iversen OH (1981)
Partial purification of the epidermal G2 chalone based on an in vivo assay system
Cell Biol Int Rep, 5 (2), 195-9
DOI 10.1016/0309-1651(81)90028-x, PubMed 6452953

Elgjo K, Clausen OP, Thorud E (1981)
Epidermis extracts (chalone) inhibit cell flux at the the G1-S, S-G2 and G2-M transitions in mouse epidermis
Cell Tissue Kinet, 14 (1), 21-9
DOI 10.1111/j.1365-2184.1981.tb00507.x, PubMed 6451294

Kolmannskog F, Aakhus T, Fausa O, Schrumpf E, Ritland S, Gjone E, Elgjo K (1981)
Cholangiographic findings in ulcerative colitis
Acta Radiol Diagn (Stockh), 22 (2), 151-7
DOI 10.1177/028418518102200208, PubMed 6269359

ROGNUM TO, THORUD E, ELGJO K, BRANDTZAEG P, ORJASAETER H, NYGAARD K, CLAUSEN OPF (1981)
DNA FLOW-CYTOMETRY (FCM) IN CARCINOMAS OF THE LARGE BOWEL COMPARED WITH THE 2 FUNCTIONAL CELL MARKERS SECRETORY COMPONENT (SC) AND CARCINOEMBRYONIC ANTIGEN (CEA), THE HISTOLOGICAL TUMOR GRADE AND THE CLINICAL STAGE - A PRELIMINARY COMMUNICATION
ACTA PATH MICRO IM A (274), 417-423

Rognum TO, Brandtzaeg P, Orjasaeter H, Elgjo K, Hognestad J (1980)
Immunohistochemical study of secretory component, secretory IgA and carcinoembryonic antigen in large bowel carcinomas
Pathol Res Pract, 170 (1-3), 126-45
DOI 10.1016/s0344-0338(80)80161-0, PubMed 18788158

Kolmannskog F, Kolbenstvedt A, Aakhus T, Bergan A, Fausa O, Elgjo K (1980)
[Computerized tomography of the pancreas]
Tidsskr Nor Laegeforen, 100 (29), 1734-8
PubMed 7466761

Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S (1980)
Sclerosing cholangitis in ulcerative colitis
Scand J Gastroenterol, 15 (6), 689-97
DOI 10.3109/00365528009181516, PubMed 7209379

Clausen OP, Thorud E, Bjerknes R, Elgjo K (1979)
Circadian rhythms in mouse epidermal basal cell proliferation. Variations in compartment size, flux and phase duration
Cell Tissue Kinet, 12 (3), 319-37
DOI 10.1111/j.1365-2184.1979.tb00154.x, PubMed 476779

Ritland S, Elgjo K, Johansen O, Steinnes E (1979)
Liver copper content in patients with inflammatory bowel disease and associated liver disorders
Scand J Gastroenterol, 14 (6), 711-5
DOI 10.3109/00365527909181942, PubMed 531503

Elgjo K, Devik F (1978)
Growth regulation in X-irradiated mouse skin; the possible role of chalones
Int J Radiat Biol Relat Stud Phys Chem Med, 34 (2), 119-26
DOI 10.1080/09553007814550711, PubMed 151082

Slaga TJ, Lichti U, Hennings H, Elgjo K, Yuspa SH (1978)
Effects of tumor promoters and steroidal anti-inflammatory agents on skin of newborn mice in vivo and in vitro
J Natl Cancer Inst, 60 (2), 425-31
DOI 10.1093/jnci/60.2.425, PubMed 621756

Bjørneklett A, Astor T, Elgjo K (1978)
[Intrahepatic cholestasis in lymphogranulomatosis]
Tidsskr Nor Laegeforen, 98 (1), 13-4
PubMed 625732

Bjørneklett A, Stavem P, Elgjo K (1978)
Relative value of sternal aspiration, iliac crest biopsy and biopsy imprint in the diagnosis of secondary cancer involvement of the bone marrow
Acta Med Scand, 203 (4), 279-81
DOI 10.1111/j.0954-6820.1978.tb14873.x, PubMed 645440

Evensen SA, Blomhoff JP, Flatmark A, Elgjo K (1978)
Peroperative endoscopic diagnosis of small intestinal bleeding
Scand J Gastroenterol, 13 (5), 593-7
DOI 10.3109/00365527809181769, PubMed 309172

Stave R, Elgjo K, Brandtzaeg P (1978)
Quantification of gastrin-producing cells (G cells) and parietal cells in relation to histopathological alterations in resected stomachs from patients with peptic ulcer disease
Scand J Gastroenterol, 13 (6), 747-57
DOI 10.3109/00365527809181791, PubMed 80819

Isaksson-Forsén G, Burton DR, Korsgaard R, Elgjo K, Iversen OH (1977)
Partial purification of epidermal G2 chalone
Virchows Arch B Cell Pathol, 26 (2), 97-103
DOI 10.1007/BF02889538, PubMed 146951

Elgjo K, Elgjo RF, Hennings H (1977)
Morphology of mouse epidermal cells in vitro: a scanning electron microscopy study
Beitr Pathol, 161 (2), 122-30
DOI 10.1016/s0005-8165(77)80091-7, PubMed 597099

Elgjo K, Cromarty A (1977)
Growth kinetics in newborn mouse epidermis: response to epidermal chalone
Virchows Arch B Cell Pathol, 24 (2), 101-8
DOI 10.1007/BF02889271, PubMed 142357

Yuspa SH, Elgjo K, Morse MA, Wiebel FJ (1977)
Retinyl acetate modulation of cell growth kinetics and carcinogen--cellular interaction in mouse epidermal cell cultures
Chem Biol Interact, 16 (3), 251-64
DOI 10.1016/0009-2797(77)90105-3, PubMed 862128

ELGJO K, CROMARTY A (1977)
GROWTH KINETICS IN NEWBORN MOUSE EPIDERMIS - RESPONSE TO EPIDERMAL CHALONE
Virchows Arch. B-Cell Molec. Pathol., 24 (2), 101-108

ISAKSSONFORSEN G, BURTON DR, KORSGAARD R, ELGJO K, IVERSEN OH (1977)
PARTIAL-PURIFICATION OF EPIDERMAL G2 CHALONE
Virchows Arch. B-Cell Molec. Pathol., 26 (2), 97-103

Iversen OH, Clausen OP, Elgjo K, Iversen UM, Rohrbach R (1977)
Effects of bleomycin on the epidermal content of growth-regulatory substances (chalones)
Cell Tissue Kinet, 10 (1), 71-9
DOI 10.1111/j.1365-2184.1977.tb00284.x, PubMed 66992

Fausa O, Nygaard K, Elgjo K (1977)
Amyloidosis and Crohn's disease
Scand J Gastroenterol, 12 (6), 657-62
DOI 10.3109/00365527709181699, PubMed 929104

Rohrbach R, Iversen OH, Elgjo K, Riede UN, Sandritter W (1976)
Effects of croton oil on epidermal growth regulators (chalones)
Beitr Pathol, 159 (2), 143-56
DOI 10.1016/s0005-8165(76)80002-9, PubMed 137713

Yuspa SH, Ben T, Patterson E, Michael D, Elgjo K, Hennings H (1976)
Stimulated DNA synthesis in mouse epidermal cell cultures treated with 12-O-tetradecanoyl-phorbol-13-acetate
Cancer Res, 36 (11 Pt 1), 4062-8
PubMed 975048

Rohrbach R, Iversen OH, Elgjo K, Sandritter W (1976)
Effects of methylcholanthrene on epidermal growth regulators. II. Variations in the S-factor
Beitr Pathol, 158 (2), 145-58
PubMed 136242

Elgjo K, Hennings H, Michael D, Yuspa SH (1976)
Natural synchrony of newborn mouse epidermal cells in vitro
J Invest Dermatol, 66 (5), 292-6
DOI 10.1111/1523-1747.ep12482235, PubMed 1270836

Iversen OH, Clausen OP, Elgjo K, Iversen UM, Rohrbach R (1976)
Growth parameters of the hairless mouse epidermis after bleomycin treatment: possible interaction with epidermal chalones
Prog Biochem Pharmacol, 11, 110-8
PubMed 63957

ROHRBACH R, IVERSEN OH, ELGJO K, SANDRITTER W (1976)
EFFECTS OF METHYLCHOLANTHRENE ON EPIDERMAL GROWTH-REGULATORS .2. VARIATIONS IN S-FACTOR
BEITR PATHOL, 158 (2), 145-158
DOI 10.1016/S0005-8165(76)80193-X

Solberg HE, Skrede S, Elgjo K, Blomhoff JP, Gjone E (1976)
Classification of liver diseases by clinical chemical laboratory results and cluster analysis
Scand J Clin Lab Invest, 36 (1), 81-5
DOI 10.1080/00365517609068022, PubMed 1257696

ROHRBACH R, IVERSEN OH, ELGJO K, RIEDE UN, SANDRITTER W (1976)
EFFECTS OF CROTON-OIL ON EPIDERMAL GROWTH-REGULATORS (CHALONES)
BEITR PATHOL, 159 (2), 143-156

Skrede S, Blomhoff JP, Elgjo K, Gjone E (1975)
Serum proteins in diseases of the liver
Scand J Clin Lab Invest, 35 (5), 399-406
DOI 10.3109/00365517509095759, PubMed 52885

DEGRE M, ELGJO K (1975)
INFLUENCE OF SYNTHETIC POLYNUCLEOTIDES AND INTERFERON ON INVITRO GROWTH OF CELLS DERIVED FROM A MOUSE SARCOMA
ACTA PATH MICRO IM A, 1974 248, 61-68

Elgjo K, Degré M (1975)
Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice
J Natl Cancer Inst, 54 (1), 219-21
DOI 10.1093/jnci/54.1.219, PubMed 1113302

Elgjo K (1975)
Epidermal chalone and cyclic AMP: an in vivo study
J Invest Dermatol, 64 (1), 14-8
DOI 10.1111/1523-1747.ep12540874, PubMed 162919

Aagenaes O, TFagerhol M, Elgjo K, Munthe E, Hovig T (1974)
Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals
Postgrad Med J, 50 (584), 365-75
DOI 10.1136/pgmj.50.584.365, PubMed 4549449

Elgjo K (1974)
Reversible inhibition of epidermal G-1 cells by repeated injections of aqueous skin extracts (chalone)
Virchows Arch B Cell Pathol, 15 (2), 157-63
DOI 10.1007/BF02889333, PubMed 4277637

Elgjo K (1974)
Evidence for presence of the epidermal G2-inhibitor ("epidermal chalone") in dermis
Virchows Arch B Cell Pathol, 16 (3), 243-7
DOI 10.1007/BF02894079, PubMed 4280183

Degré M, Elgjo K (1974)
Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma
Acta Pathol Microbiol Scand Suppl, Suppl 248, 61-8
PubMed 4217556

Tönder M, Nordöy A, Elgjo K (1974)
Sulfonamide-induced chronic liver disease
Scand J Gastroenterol, 9 (1), 93-6
PubMed 4453809

ELGJO K (1974)
REVERSIBLE INHIBITION OF EPIDERMAL G-1 CELLS BY REPEATED INJECTIONS OF AQUEOUS SKIN EXTRACTS (CHALONE)
VIRCHOWS ARCH B, 15 (2), 157-163

Elgjo K, Larsen TE (1973)
Alterations in epidermal growth kinetics induced by coal tar ointment and methotrexate
J Invest Dermatol, 61 (1), 22-4
DOI 10.1111/1523-1747.ep12673906, PubMed 4718751

Elgjo K, Edgehill W (1973)
Epidermal growth inhibitors (chalones) in dermis and serum
Virchows Arch B Cell Pathol, 13 (1), 14-23
DOI 10.1007/BF02889293, PubMed 4267982

Skrede S, Blomhoff JP, Elgjo K, Gjone E (1973)
Biochemical tests in evaluation of liver function
Scand J Gastroenterol Suppl, 19, 37-46
PubMed 4515640

SKREDE S, BLOMHOFF JP, ELGJO K, GJONE E (1973)
BIOCHEMICAL TESTS IN EVALUATION OF LIVER FUNCTION
Scand. J. Gastroenterol., 8 19, 37-46

Fausa O, Fretheim B, Elgjo K, Semb L, Gjone E (1973)
Intractable watery diarrhoea, hypokalaemia, and achlorhydria associated with non-pancreatic retroperitoneal neurogenous tumour containing vasoactive intestinal peptide (V.I.P.)
Scand J Gastroenterol, 8 (8), 713-7
PubMed 4771110

Ritland S, Blomhoff JP, Elgjo K, Gjone E (1973)
Lipoprotein-X (LP-X) in liver disease
Scand J Gastroenterol, 8 (2), 155-60
PubMed 4697077

ELGJO K (1973)
EPIDERMAL CHALONE - CELL CYCLE SPECIFICITY OF 2 EPIDERMAL GROWTH INHIBITORS
NATL CANCER I MONOGR (M38), 71-76

Husby G, Blomhoff JP, Skrede S, Elgjo K, Gjone E (1973)
Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis
Scand J Gastroenterol, 8 (7), 621-9
PubMed 4588517

ELGJO K, EDGEHILL W (1973)
EPIDERMAL GROWTH INHIBITORS (CHALONES) IN DERMIS AND SERUM
VIRCHOWS ARCH B, 13 (1), 14-23

Stavem P, Saltvedt E, Elgjo K, Rootwelt K (1973)
Congenital hypochromic microcytic anaemia with iron overload of the liver and hyperferraemia
Scand J Haematol, 10 (2), 153-60
DOI 10.1111/j.1600-0609.1973.tb00053.x, PubMed 4731089

Ritland S, Elgjo K (1972)
[Granulomatous hepatitis]
Tidsskr Nor Laegeforen, 92 (35), 2416-20
PubMed 4657018

Aagenaes O, Matlary A, Elgjo K, Munthe E, Fagerhol M (1972)
Neonatal cholestasis in alpha-1-antitrypsin deficient children. Clinical, genetic, histological and immunohistochemical findings
Acta Paediatr Scand, 61 (6), 632-42
DOI 10.1111/j.1651-2227.1972.tb15960.x, PubMed 4117022

Christoffersen T, Morland J, Osnes JB, Elgjo K (1972)
Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen
Biochim Biophys Acta, 279 (2), 363-6
DOI 10.1016/0304-4165(72)90153-5, PubMed 4343215

Elgjo K (1972)
Chalone inhibition of cellular proliferation
J Invest Dermatol, 59 (1), 81-3
DOI 10.1111/1523-1747.ep12625842, PubMed 4339134

Elgjo K (1972)
[Amyloidosis]
Tidsskr Nor Laegeforen, 92 (11), 788-9
PubMed 4112894

Elgjo K (1972)
[Cellular and vascular elements and the connective tissue reaction in inflammation]
Tidsskr Nor Laegeforen, 92 (11), 739-41
PubMed 5028885

Blomhoff JP, Elgjo K, Gjone E (1972)
[Chronic hepatitis]
Tidsskr Nor Laegeforen, 92 (4), 254-6
PubMed 5016487

Elgjo K, Laerum OD, Edgehill W (1972)
Growth regulation in mouse epidermis. II. G 1 -inhibitor present in the differentiating cell layer
Virchows Arch B Cell Pathol, 10 (3), 229-36
DOI 10.1007/BF02899732, PubMed 4260718

Gjone E, Blomhoff JP, Ritland S, Elgjo K, Husby G (1972)
Laxative-induced chronic liver disease
Scand J Gastroenterol, 7 (4), 395-402
DOI 10.3109/00365527209180760, PubMed 5048755

Rohrbach R, Elgjo K, Iversen OH, Sandritter W (1972)
Effects of methylcholanthrene on epidermal growth regulators. I. Variations in the M-factor
Beitr Pathol, 147 (1), 21-7
DOI 10.1016/s0005-8165(72)80006-4, PubMed 5078908

Bronstad GO, Elgjo K, Oye I (1971)
Adrenaline increases cyclic 3'5'-AMP formation in hamster epidermis
Nat New Biol, 233 (37), 78-9
DOI 10.1038/newbio233078a0, PubMed 4330298

Degré M, Elgjo K (1971)
Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C)
Acta Pathol Microbiol Scand A, 79 (6), 687-8
PubMed 5123526

Hennings H, Elgjo K (1971)
Hydrocortisone: inhibition of DNA synthesis and mitotic rate after local application to mouse epidermis
Virchows Arch B Cell Pathol, 8 (1), 42-9
DOI 10.1007/BF02893513, PubMed 4995721

Elgjo K, Hennings H (1971)
Epidermal chalone and cell proliferation in a transplantable squamous cell carcinoma in hamsters. I. In vivo results
Virchows Arch B Cell Pathol, 7 (1), 1-7
DOI 10.1007/BF02892073, PubMed 4250919

Sigstad H, Haugland T, Fretheim B, Elgjo K (1971)
Adenomyomatosis of the gallbladder. Report of a case
Acta Chir Scand, 137 (2), 185-8
PubMed 5149492

Elgjo K, Laerum OD, Edgehill W (1971)
Growth regulation in mouse epidermis. I. G 2 -inhibitor present in the basal cell layer
Virchows Arch B Cell Pathol, 8 (4), 277-83
DOI 10.1007/BF02893536, PubMed 4998657

Laurence EB, Elgjo K (1971)
Epidermal chalone and cell proliferation in a transplantable squamous cell carcinoma in hamsters. II. In vitro results
Virchows Arch B Cell Pathol, 7 (1), 8-15
DOI 10.1007/BF02892074, PubMed 4250920

Elgjo K, Hennings H (1971)
Epidermal mitotic rate and DNA synthesis after injection of water extracts made from mouse skin treated with Actinomycin D: two or more growth-regulating substances?
Virchows Arch B Cell Pathol, 7 (4), 342-7
DOI 10.1007/BF02892102, PubMed 4251628

Hennings H, Elgjo K (1970)
Epidermal regeneration after cellophane tape stripping of hairless mouse skin
Cell Tissue Kinet, 3 (3), 243-52
DOI 10.1111/j.1365-2184.1970.tb00269.x, PubMed 5523054

Jellum E, Elgjo K (1970)
S-Alkylglutathione, methylglyoxal metabolism and cell division
Biochem Biophys Res Commun, 38 (4), 575-82
DOI 10.1016/0006-291x(70)90620-0, PubMed 5443701

Gjone E, Fretheim B, Nordöy A, Jacobsen CD, Elgjo K (1970)
Intractable watery diarrhoea, hypokalaemia, and achlorhydria associated with pancreatic tumour containing gastric secretory inhibitor
Scand J Gastroenterol, 5 (5), 401-8
PubMed 5455827

Stavem P, Hjort PF, Elgjo K, Sommerschild H (1970)
Solitary plasmocytoma of the spleen with marked polyclonal increase of gamma G, normalized after splenectomy
Acta Med Scand, 1-2 (1), 115-8
DOI 10.1111/j.0954-6820.1970.tb08013.x, PubMed 4097032

Hennings H, Elgjo K, Iversen OH (1969)
Delayed inhibition of epidermal DNA synthesis after injection of an aqueous skin extract (chalone)
Virchows Arch B Cell Pathol, 4 (1), 45-53
DOI 10.1007/BF02906060, PubMed 4982324

Elgjo K (1969)
Epidermal cell proliferation during the first 24 hr after injection of an aqueous skin extract (Chalone)
Virchows Arch B Cell Pathol, 4 (2), 119-25
DOI 10.1007/BF02906066, PubMed 4982799

Elgjo K (1969)
The stability of the epidermal mitosis inhibiting factor (chalone) in water solution
Acta Pathol Microbiol Scand, 76 (1), 31-4
PubMed 4242632

Elgjo K (1969)
Cell renewal of the normal mouse cornea
Acta Pathol Microbiol Scand, 76 (1), 25-30
DOI 10.1111/j.1699-0463.1969.tb03229.x, PubMed 5350749

Elgjo K (1968)
Epidermal cell population kinetics after repeated applications of some hyperplasia-producing substances
Eur J Cancer (1965), 4 (2), 183-92
DOI 10.1016/0014-2964(68)90016-9, PubMed 5760793

Elgjo K (1968)
Epidermal cell population kinetics after a single application of some hyperplasia-producing substances
Eur J Cancer (1965), 3 (6), 519-30
DOI 10.1016/0014-2964(68)90090-x, PubMed 5636121

Elgjo K (1968)
Growth kinetics of the mouse epidermis after a single application of 3,4-benzopyrene, croton oil, or 1,2-benzopyrene
Acta Pathol Microbiol Scand, 73 (2), 183-90
DOI 10.1111/j.1699-0463.1968.tb00491.x, PubMed 5662495

Elgjo K (1968)
Growth kinetics of the mouse epidermis after a single application of cigarette smoke condensates
Acta Pathol Microbiol Scand, 73 (3), 316-22
DOI 10.1111/j.1699-0463.1968.tb04600.x, PubMed 5681807

ELGJO K (1965)
KINETICS OF CELLULAR GROWTH AFTER REPEATED APPLICATIONS OF METHYLCHOLANTHRENE
Nature, 205, 407-8
DOI 10.1038/205407b0, PubMed 14243439

Iversen OH, Aandahl E, Elgjo K (1965)
The effect of an epidermis-specific mitotic inhibitor (chalone) extracted from epidermal cells
Acta Pathol Microbiol Scand, 64 (4), 506-10
DOI 10.1111/apm.1965.64.4.506, PubMed 5829962

Elgjo K, Opsahl R (1964)
Metastasis to the chamber angle from mucoid breast carcinoma
Acta Ophthalmol (Copenh), 42 (4), 881-3
DOI 10.1111/j.1755-3768.1964.tb01741.x, PubMed 4295736

ELGJO K (1963)
DURATION AND RATE OF MITOSIS AFTER A SINGLE APPLICATION OF METHYLCHOLANTHRENE
Nature, 200, 608
DOI 10.1038/200608a0, PubMed 14082256

ELGJO K (1961)
[Protein loss from the stomach and intestines]
Tidsskr Nor Laegeforen, 81, 833-4
PubMed 13726339

Review articles

Elgjo K, Reichelt KL, Gembitsky DS (1998)
Growth-inhibiting N-substituted endogenous peptides
Prog Mol Subcell Biol, 20, 143-59
DOI 10.1007/978-3-642-72149-6_7, PubMed 9928529

Elgjo K, Reichelt KL, Reichelt WH (1995)
Biologically active pyroglutamyl N-terminal oligopeptides: parts of larger molecules?
Physiol Chem Phys Med NMR, 27 (4), 351-3
PubMed 8768790

Moum B, Aukrust P, Schrumpf E, Mørk T, Mathisen O, Elgjo K (1992)
[Natural products can be hazardous to health]
Tidsskr Nor Laegeforen, 112 (10), 1308-11
PubMed 1579916

Schrumpf E, Fausa O, Elgjo K, Kolmannskog F (1988)
Hepatobiliary complications of inflammatory bowel disease
Semin Liver Dis, 8 (3), 201-9
DOI 10.1055/s-2008-1040541, PubMed 3068805

Elgjo K (1967)
[Nitrosamines--a new group of carcinogens]
Nord Med, 77 (5), 142-8
PubMed 5335591